IRIS - Res&Arch Institutional Research Information System - Research & Archive

LAZZERI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.183
EU - Europa 3.874
AS - Asia 2.980
SA - Sud America 583
Continente sconosciuto - Info sul continente non disponibili 233
AF - Africa 63
OC - Oceania 6
Totale 12.922
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.952
SG - Singapore 1.203
IT - Italia 1.023
UA - Ucraina 645
IE - Irlanda 501
HK - Hong Kong 486
SE - Svezia 453
BR - Brasile 446
RU - Federazione Russa 409
CN - Cina 390
VN - Vietnam 372
DE - Germania 199
FR - Francia 165
FI - Finlandia 160
KR - Corea 160
CA - Canada 127
GB - Regno Unito 97
BD - Bangladesh 70
IN - India 65
TR - Turchia 50
AR - Argentina 46
BE - Belgio 33
CH - Svizzera 33
NL - Olanda 32
PL - Polonia 32
CO - Colombia 29
AT - Austria 27
MX - Messico 27
UZ - Uzbekistan 22
PK - Pakistan 21
IQ - Iraq 20
CR - Costa Rica 18
JP - Giappone 17
SA - Arabia Saudita 17
ES - Italia 16
ID - Indonesia 16
ZA - Sudafrica 16
VE - Venezuela 14
EC - Ecuador 12
CL - Cile 11
GT - Guatemala 11
LB - Libano 10
PY - Paraguay 10
CZ - Repubblica Ceca 9
MA - Marocco 9
TN - Tunisia 9
TT - Trinidad e Tobago 8
EG - Egitto 7
EU - Europa 7
JM - Giamaica 7
NI - Nicaragua 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
IR - Iran 6
UY - Uruguay 6
AL - Albania 5
AU - Australia 5
BO - Bolivia 5
HN - Honduras 5
JO - Giordania 5
RO - Romania 5
TH - Thailandia 5
CW - ???statistics.table.value.countryCode.CW??? 4
DZ - Algeria 4
GR - Grecia 4
KE - Kenya 4
MY - Malesia 4
PR - Porto Rico 4
BG - Bulgaria 3
DK - Danimarca 3
EE - Estonia 3
ET - Etiopia 3
LT - Lituania 3
NP - Nepal 3
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
BZ - Belize 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GP - Guadalupe 2
HU - Ungheria 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
SV - El Salvador 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CY - Cipro 1
Totale 12.674
Salva come PNG Salva come JPEG
Città #
Singapore 820
Chandler 614
Dublin 500
Ashburn 491
Hong Kong 479
San Jose 369
Jacksonville 315
San Mateo 304
Dong Ket 237
Boardman 186
Santa Clara 174
Seoul 160
Council Bluffs 154
Princeton 128
Medford 127
Moscow 126
Lauterbourg 106
Wilmington 103
Altamura 88
Beijing 86
Perugia 78
Rome 77
Des Moines 72
Lawrence 71
Andover 68
Ann Arbor 68
New York 63
Milan 55
Los Angeles 52
Ottawa 52
São Paulo 49
Piscataway 48
Shanghai 44
Saint Petersburg 42
Ho Chi Minh City 40
Munich 35
Brussels 33
Hanoi 33
Dallas 31
Izmir 26
Norwalk 25
Orem 25
Atlanta 23
Helsinki 21
The Dalles 21
Toronto 21
Frankfurt am Main 19
Florence 18
Montreal 18
Naples 18
Phoenix 18
Vienna 18
Warsaw 18
Falls Church 17
Tokyo 17
San Paolo di Civitate 16
North Bergen 15
San Francisco 15
Woodbridge 15
Chicago 14
Charlotte 13
Chennai 13
Redwood City 13
Rio de Janeiro 13
Tashkent 13
Turku 12
Brooklyn 11
San José 11
Turin 11
Bologna 10
Houston 10
Riyadh 10
Baghdad 9
Buffalo 9
Johannesburg 9
Manchester 9
Medellín 9
Philadelphia 9
Ribeirão Preto 9
Dhaka 8
Istanbul 8
Terni 8
Belo Horizonte 7
Da Nang 7
Den Haag 7
Guatemala City 7
Islamabad 7
London 7
Managua 7
New Delhi 7
Stockholm 7
West Jordan 7
Amsterdam 6
Brasília 6
Buenos Aires 6
Cagliari 6
Caracas 6
Chaguanas 6
Columbus 6
Denver 6
Totale 7.321
Salva come PNG Salva come JPEG
Nome #
Ruolo della colposospensione sec.Burch associata a ricostruzione integrale per via addominale in pazienti continenti e incontinenti affette da prolasso urogenitale avanzato. Rivalutazione a lungo termine di 2 studi clinici randomizzati 448
1 hour pad test ha un basso valore predittivo nella diagnosi dell’incontinenza urinaria femminile 435
ABDOMINAL VS LAPAROSCOPIC SACROPEXY: SUBGROUP ANALYSIS OF A PROSPECTIVE RANDOMIZED TRIAL 290
DIAGNOSI ECOGRAFICA DI DEFICIT SFINTERICO URETRALE NELLA DONNA 279
1-hour pad test has low predictive value in the diagnosis of women with urinary incontinence 249
Abdominal integral pelvic reconstruction plus or minus Burch colposuspension in the treatment of severe uro-genital prolapse associated to urinary incontinence. A RCT with a mid-term follow up 199
Bacillus Calmette-Guérin versus Gemcitabine for intravesical therapy in high-risk superficial bladder cancer: a randomised prospective study 178
Valutazione dell’attività sessuale mediante questionario FSFI in pazienti sottoposte a sling medio-uretrale: studio multicentrico 174
Evaluation of Prostate-Specific Antigen Isoform p2PSA and Its Derivates, %p2PSA, Prostate Health Index and Prostate Dimension-Adjusted Related Index in the Detection of Prostate Cancer at First Biopsy: An Exploratory, Prospective Study. 156
Abdominal pelvic floor reconstruction with uterus preservation 154
Performance of incontinence impact questionnaire (IIQ) in italian population according to educational status 153
Abdominal vs laparoscopic sacrocolpopexy: subgroup analysis of a prospective randomized trial 148
Prulifloxacin vs Phosphomycin: Prophylaxis in patients with recurrent UTI. Preliminary results of a randomized multi-centre study 140
Risultati chirurgici nelle donne in età avanzata 136
Is surgical outcome at risk during post-graduated educational courses for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) repair? A case control study 132
Long-term outcome of anti-incontinence procedure during Pelvic Organ Prolapse repair in patients with or without urinary incontinence: results from two randomized surgical trials 132
Master di II livello in uroginecologia: quali i risultati chirurgici 131
POLYVINYLIDENFLUORID (PVDF) AND POLYPROPYLENE MESH FOR SACROCOLPOPEXY: A COMPARATIVE STUDY 129
Valutazione dell’attività sessuale pre e post operatoria mediante questionario FSFI in pazienti sottoposti a sling medio uretrale 128
Uterovaginal prolapse in a woman desiring uterus preservation. Case Presentation with Expert discussion 128
Management of healing abnormalities after abdominal pelvic organ prolapse repair 123
Chirurgia del prolasso con preservazione dell’utero: risultati a lungo termine 119
Female sexual function evaluation in patients who underwent integral pelvic floor reconstructive surgery 118
Overactive bladder symptoms (OAB) and detrusor overactivity (DO) in patients with posterior vault prolapse: Prevalence and its changes after POP repair 117
Surgical outcome during post-graduated educational courses for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) repair: case control study 115
Il ruolo del MUCP e del VLPP preoperatori nel predirre i risultati delle pazienti sottoposte a TOT 115
Long-Term follow-up uterus sparing surgery for pelvic organ prolapse (POP) 115
Editorial comment on: Cizolirtine Citrate is safe and effective for treating Urinary Incontinence secondary to overactive bladder: a Phase 2 proof-of-concept study 114
Bcg vs. Gemcitabina per la terapia endovescicale del carcinoma uroteliale ad alto rischio: Studio prospettico randomizzato 112
Retropubic versus transobturator mid-urethral slings: in a randomised controlled trial pre-operative VLPP may not predict mid-term outcome 109
Uro-genital prolapse surgery: update on post-operative urinary incontinence 109
Cambiamenti della funzione sessuale nelle pazienti con sling medio-uretrali per incontinenza urinaria da stress 109
FSFI: modificazioni dell’attività sessuale pre e post-intervento nelle pazienti sottoposte a chirurgia ricostruttiva del pavimento pelvico 108
Burch colposuspension does not provide any additional benefit to pelvic organ prolapse repair in patients with urinary incontinence: A randomized surgical trial 107
The management of healing abnormalities after abdominal pelvic organ prolapse repair 104
Patients of surgical educational course may have a poorer outcome for pelvic organ prolapse repair and higher complication rate: a case-control study in urogynecology 104
Burch colposuspension and pelvic organ prolapse repair in patients with and without urinary incontinence: results from two randomised surgical trials 104
Preoperative urinary incontinence is the main risk factor for post-operative incontinence in women who underwent POP (Pelvic Organ Prolapse) repair 103
Open-Label, Longitudinal Study of Tamsulosin for Functional Bladder Outlet Obstruction in Women 102
Fattori di rischio per l’incontinenza urinaria post-operatoria in pazienti affette da prolasso severo e sottoposte a ricostruzione integrale del pavimento pelvico 102
IMPACT OF MID URETHRAL SLING ON FEMALE SEXUAL FUNCTION. A PROSPECTIVE MULTICENTRE STUDY 101
Prulifloxacin vs fosfomycin for prophylaxis in female patients with recurrent UTIs: a non-inferiority trial. 101
Prevalence of sexual activity in waiting list women for pelvic organ prolapse and/or urinary incontinence surgery: a cross sectional survey 101
Urinary Tract Infections in Women With Type 1 Diabetes Mellitus: Survey of Female Participants in the Epidemiology of Diabetes Interventions and Complications Study Cohort COMMENT 100
Uterus sparing surgery: A paradigm shift. Effectively managing POP includes prioritising patient’s wish 100
Profilassi con Plurifloxacina vs Fosfomicina in pawienti affette da cistiti ricorrenti. Risultati preliminari di uno studio randomizzato 100
Managing Mesh Erosion after Abdominal Pelvic Organ Prolapse Repair: Ten Years Experience in a Single Center 99
Laparoscopic Versus Abdominal Sacrocolpopexy: A Randomized, Controlled Trial 98
Changes in female sexual function after pelvic organ prolapse repair: role of hysterectomy 98
Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections: a European multicentre nested case-control study 95
Pre-operative VLPP may not predict the mid-term out come of mid-urethral slings. A retrospective analysis from a randomized controller trial of TVT versus TOT mid-urethral slings 94
Deterioration of continence after TOT when the follow-up is extended: results from a randomised controlled study 94
Preoperative urinary incontinence is the main risk factor for post-operative incontinence in women who underwent pelvic organ prolapse repair 93
Profilassi in pazienti affette da cistiti ricorrenti: risultati preliminari di uno studio randomizzato multicentrico; prulifloxacina vs fosfomicina 92
Sexual activity before and after mid urethral sling. A prospective multicentre study 92
Preoperative urinary incontinence is the main risk factor for post operative incontinence in women who underwent pelvic organ prolapse repair 92
Impact of a teaching program on outcome quality of white light transurethral resection for bladder tumor: A cohort study 92
Preoperative MUCP and VLPP failed to predict outcome in patients who underwent transobturator mid-urethral slings 91
Five-year outcome of uterus sparing surgery for pelvic organ prolapse repair: a single-center experience 91
Prolasso di volta a prevalenza posteriore: relazione con i sintomi da vescica iperattiva e con l’iperattività detrusoriale prima e dopo intervento chirurgico 91
Managing complications after midurethral sling for stress urinary incontinence 90
Il ruolo degli ultrasuoni nella definizione del deficit sfinterico uretrale 90
Surgical outcomes in aging women 90
The Incontinence Impact Questionnaire: Results in an Italian Female Population Stratified by Educational Status 90
Morphological changes of bladder mucosa in patients who underwent instillation with combined sodium Hyaluronate-chondroitin sulphate (Ialuril®). 90
Colposacropessia laparoscopica versus Colposacropessia addominale: subanalisi di uno studio randomizzato 90
Cost-utility rations (CURs) and different levels of effectiveness in urinary incontinence (UI) management 89
Are We in a Robotic Surgical Bubble Market? 89
Is the tension-free vaginal tape procedure for stress urinary incontinence safe and effective in the long term? 89
Uterus preservation in pelvic organ prolapse surgery 87
Urodynamics for Pelvic Organ Prolapse Surgery: "Par for the Course" 87
Uterus sparing surgery for pelvic organ prolapse (POP): long term results 85
Long-term outcome of anti-incontinence procedure during pelvic organ prolapse repair in patients with and without urinary incontinence: results from two randomised controlled trials 85
Lean Mean Research: The 21st Century Challenge for Urology 85
Sexual changes after pop repair. Is hysterectomy a key element? 85
Treatment of severe uro-genital prolapse associated with urinary incontinence by means of abdominal integral pelvic floor reconstruction with or without Burch colposuspension. A RCT with a mid-term follow-up 85
Iatrogenic Trapped Penis in Adults: New, Simple 2-Stage Repair 84
Preoperative MUCP and VLPP may not predict mid-term outcome in patients who underwent transobturator mid-urethral slings (TOT) 84
Sexual changes after POP repair. Is hysterectomy a key element? 82
The Challenge of the Overactive Bladder: From Laboratory to New Drugs 82
Hydronephrosis and Pelvic Organ Prolapse 81
Preoperative Valsava Leak Point Pressure May Not Predict Outcome of Mid-Urethral Slings. Analysis from a Randomized Controlled Trial of Retropubic versus Transobturator Mid-Urethral Slings 81
Pelvic Organ Prolapse Repair With and Without Prophylactic Concomitant Burch Colposuspension in Continent Women: A Randomized, Controlled Trial With 8-Year Followup 81
L’analisi costo-utilità nel trattamento dell’incontinenza urinaria femminile 80
Long-term efficacy of the trans-obturator and retropubic mid-urethral slings for stress urinary incontinence: update from a randomized clinical trial 80
Hysterectomy and stress urinary incontinence. 78
Posterior vault prolapse and overactive bladder symptoms (OAB): changes after POP repair 78
Is surgical outcome at risk during post-graduated educational courses for stress urinary incontinence (sui) and pelvic organ prolapse (pop) repair? A case control study 77
GAGs and GAGs diseases: when pathophysiology supports the clinic 77
Editorial comment on: Tension free vaginale tape in the management of recurrent urodynamics stress incontinence after previous failed midurethral tape 76
Long-term Efficacy of the Transobturator and Retropubic Midurethral Slings for Stress Urinary Incontinence: Single-center Update from a Randomized Controlled Trial. 75
Intravesical administration of combined hyaluronic acid and chondroitin sulphate vs standard of care for the treatment of female recurrent urinary tract infections (RUTIs): What did we learn from a multicentre European real life setting case-control study? 75
Sensitivity and specificity of one-hour pad test as a predictive value for female urinary incontinence 75
Il trattamento delle complicanze dopo chirurgia addominale per il prolasso degli organi pelvici 74
Cost-Utility Ratios (CURS) and different levels of effectiveness in urinary incontinence (UI) management 74
Morphological Changes of Bladder Mucosa in Patients Who Underwent Instillation with Combined Sodium Hyaluronic Acid-Chondroitin Sulphate (Ialuril®) 74
Long-term follow-up of uterus sparing surgery for pelvic organ prolapse (POP) 72
Pelvic organ prolapse and lower urinary tract symptoms: experience from a high-volume uro-gynecologic center 70
Risultati anatomo/funzionali e tasso di complicanze in pazienti sottoposte a intervento chirurgico durante corsi educazionali. Studio Caso Controllo 69
Ureteroidronefrosi e prolasso degli organi pelvici 69
Totale 11.297
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.485
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.485
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022825 0 0 0 76 47 12 12 286 11 28 146 207
2022/20231.923 179 326 36 137 134 227 5 121 664 7 61 26
2023/2024952 34 83 45 23 16 15 295 81 117 22 127 94
2024/20251.608 79 173 86 48 260 64 15 114 315 108 204 142
2025/20263.232 265 214 139 435 365 272 556 126 369 330 109 52
2026/20271.178 80 130 280 688 0 0 0 0 0 0 0 0
Totale 12.922